文献速递脊柱脊髓外科神经肿瘤

54例乳腺癌脊柱转移的手术疗效与预后分析

Surgical Efficacy and Prognosis of 54 Cases of Spinal Metastases from Breast Cancer.
PubMed 文献 · World Neurosurg · 2022-06-22

回顾性分析2017年1月至2020年10月在本院经多学科会诊后行开放手术的54例乳腺癌脊柱转移患者,评估手术疗效、并发症、生存及影响因素,并验证SORG等评分系统对术后1年生存的预测能力。SORG网页版对术后1年生存预测能力良好;激素不敏感型和合并脑转移是预后不良的独立危险因素。

要点

  • 54例乳腺癌脊柱转移患者开放术后平均生存32.2个月,1年生存率77.8%。
  • 激素不敏感型和合并脑转移是预后不良的独立危险因素。
  • SORG网页版对术后1年生存预测能力良好。

核心结论

  • 乳腺癌脊柱转移手术治疗效果好、术后复发率低、术后生存期相对较长。
  • 激素不敏感型、合并脑转移的患者预后较差,SORG网页版能较准确预测患者1年生存。

研究设计与样本

  • 回顾性研究纳入2017年1月至2020年10月在本院经多学科会诊后行开放手术的54例乳腺癌脊柱转移患者,收集人口学、乳腺癌相关、脊柱疾病相关及治疗相关变量。
  • 采用Kaplan-Meier法绘制生存曲线,log-rank法进行单因素检验,Cox模型进行多因素分析;通过绘制受试者工作特征曲线并计算曲线下面积,检验Tomita评分、改良Tokuhashi评分、改良Bauer评分、改良Katagiri评分及SORG原始版、SORG列线图版、SORG网页版对术后1年生存的预测能力。

主要发现

  • 54例患者平均年龄51.3±8.6岁;21例行椎体减瘤术,32例行姑息性椎管减压术,1例行椎体整块切除术,手术时间229.3±87.6分钟,术中出血1018.1±931.1 mL。
  • 术后患者疼痛明显缓解、神经损伤逐渐恢复;主要手术并发症包括脑脊液漏、继发性脊髓损伤、脊柱肿瘤进展和固定断裂。
  • 平均生存32.2个月,6个月生存率90.7%,1年生存率77.8%,2年生存率60.3%。
  • 单因素分析显示术前神经功能缺损、激素不敏感型、合并脑转移是预后不良的潜在危险因素;多因素分析显示激素不敏感型和合并脑转移是与预后不良相关的独立危险因素。
  • SORG网页版对乳腺癌脊柱转移患者术后1年生存具有良好预测能力。

关键数值与推荐

  • SORG网页版对乳腺癌脊柱转移患者术后1年生存预测能力良好。
  • 平均生存32.2个月,6个月生存率90.7%,1年生存率77.8%,2年生存率60.3%。
  • 手术时间229.3±87.6分钟,术中出血1018.1±931.1 mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the efficacy and complications of spinal metastasis surgery for breast cancer; to understand the survival and the influencing factors; and to verify the predictive ability of the currently used spinal metastasis cancer survival prediction scoring system on 1 year postoperative survival. METHODS: A retrospective study was conducted of 54 patients with spinal metastases from breast cancer who underwent open surgery after multidisciplinary consultation in our hospital from January 2017 to October 2020. Patient demographic-related variables, breast cancer-related variables, spinal disorder-related variables, and treatment-related variables were collected. Survival curves were plotted using the Kaplan-Meier method, 1-way tests were performed using the log-rank method for factors that might affect prognosis, and candidate variables were included in the Cox model for multifactor analysis. The Tomita score, modified Tokuhashi score, modified Bauer score, and modified Katagiri score were examined by plotting the subject operating characteristic curve and calculating the area under the curve. The area under the curve was used to test the predictive ability of the SORG (Skeletal Oncology Research Group) original version, SORG line graph version, and SORG Web version for 1-year postoperative survival in patients with spinal metastases from breast cancer. RESULTS: The average age was 51.3 ± 8.6 years in 54 patients. Twenty-one patients underwent vertebral body debulking surgery, 32 patients underwent palliative canal decompression, and 1 patient underwent vertebral en bloc resection, with an operative time of 229.3 ± 87.6 minutes and intraoperative bleeding of 1018.1 ± 931.1 mL. Postoperatively, the patient experienced significant pain relief and gradual recovery from nerve injury. Major surgical complications included cerebrospinal fluid leakage, secondary spinal cord injury, spinal tumor progression, and broken fixation. The mean survival was 32.2 months, including a 6-month survival of 90.7%, a 1-year survival of 77.8%, and a 2-year survival of 60.3%. Univariate analysis showed that preoperation with neurologic deficits, hormone-insensitive type, with brain metastases were potential risk factors for poor prognosis. Multifactorial analysis showed that hormone-insensitive type and concomitant brain metastasis were independent risk factors associated with poor prognosis. The SORG Web version had good ability to predict 1-year postoperative survival in patients with spinal metastases from breast cancer. CONCLUSIONS: Spinal metastasis from breast cancer has good surgical efficacy, low postoperative recurrence rate, and relatively long survival after surgery. Patients with hormone-insensitive type, with brain metastasis, have a poor prognosis, and SORG Web version can predict patients' 1-year survival more accurately.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Weitao Y, Zhihuang L, Liangyu G, et al. Surgical Efficacy and Prognosis of 54 Cases of Spinal Metastases from Breast Cancer. World Neurosurg. 2022. PMID: 35750145. doi:10.1016/j.wneu.2022.06.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。